Login / Signup

Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol.

Rosalind AdamSaravanakumar KanakarajanUzunma OnyeakaziMalachy ColumbHelen Galley
Published in: BMJ open (2020)
ISRCTN12861060.
Keyphrases
  • phase ii
  • study protocol
  • chronic pain
  • placebo controlled
  • double blind
  • clinical trial
  • open label
  • randomized controlled trial
  • phase iii
  • pain management